PMID- 10774586 OWN - NLM STAT- MEDLINE DCOM- 20000731 LR - 20190921 IS - 0166-3542 (Print) IS - 0166-3542 (Linking) VI - 45 IP - 1 DP - 2000 Jan TI - Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication. PG - 9-17 AB - Recently, the antiviral 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) was shown to inhibit the replication of the infectious pancreatic necrosis virus (IPNV). In order to obtain more information about the mechanism of the antiviral action of EICAR we studied its effect on viral macromolecules synthesis. EICAR was found to inhibit IPNV messenger and genomic RNA synthesis. To inhibit viral RNA synthesis, EICAR must be added at least 3 h before the start of RNA synthesis. This suggests that EICAR does not directly affect the viral RNA polymerization process. Moreover, the antiviral action of EICAR was reversed by the exogenous addition of guanosine (5-50 microg/ml), but not adenosine or cytidine (10-100 microg/ml). Our findings suggest that the antiviral action of EICAR is mediated by a reduction of the intracellular guanosine 5'-triphosphate (GTP) pool level, as has been observed with ribavirin and EICAR in other biological systems. FAU - Jashes, M AU - Jashes M AD - Departamento de Ciencias Biologicas, Facultad de Quimica y Biologia, Universidad de Santiago de Chile. FAU - Mlynarz, G AU - Mlynarz G FAU - De Clercq, E AU - De Clercq E FAU - Sandino, A M AU - Sandino AM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Antiviral Res JT - Antiviral research JID - 8109699 RN - 0 (Antiviral Agents) RN - 0 (RNA, Messenger) RN - 0 (RNA, Viral) RN - 0 (Ribonucleosides) RN - 0 (Viral Proteins) RN - 118908-07-9 (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) RN - 12133JR80S (Guanosine) SB - IM MH - Animals MH - Antiviral Agents/*pharmacology MH - Birnaviridae Infections/*virology MH - Cell Line MH - Guanosine/metabolism MH - Infectious pancreatic necrosis virus/*drug effects/physiology MH - RNA, Messenger/biosynthesis MH - RNA, Viral/biosynthesis MH - Ribonucleosides/*pharmacology MH - Salmon/embryology MH - Transcription, Genetic/drug effects MH - Viral Proteins/metabolism MH - Virus Replication/*drug effects EDAT- 2000/04/25 09:00 MHDA- 2000/08/06 11:00 CRDT- 2000/04/25 09:00 PHST- 2000/04/25 09:00 [pubmed] PHST- 2000/08/06 11:00 [medline] PHST- 2000/04/25 09:00 [entrez] AID - S0166-3542(99)00071-6 [pii] AID - 10.1016/s0166-3542(99)00071-6 [doi] PST - ppublish SO - Antiviral Res. 2000 Jan;45(1):9-17. doi: 10.1016/s0166-3542(99)00071-6.